A repository of Oncology at Home programs and pilots, including a market overview, common success factors and challenges, and individual case profiles.
Key Takeaways:
At-home drug administration and telehealth follow-up are the most common types of oncology care delivered at home. Much like other models of home-based care, digital innovations around telehealth and RPM are driving the expansion.
LHS report high patient satisfaction with oncology at home. Early indicators suggest home-based cancer care reduces time spent in the hospital for patients and removes travel barriers for patients.
There are additional safety concerns with oncology at home programs. Drug administration in particular presents risk. To prevent allergic reactions at home, most programs require the first cancer drug administration at a hospital or ambulatory clinics.
The most common challenges for LHS implementing home-based patient care: sustainable patient enrollment and reimbursement strategies. LHS are navigating the regulatory maze to stand up home-based oncology with the right orchestration of staff, technology, and strategic partnerships.
Health systems partner to leverage vendor expertise in strategy consulting, cultural know-how, and technology platforms to scale up home cancer care. External partnerships help LHS manage logistics and implement home-based cancer care with their own care team.
Program maturity of home-based cancer care lags behind hospital-at-home. Complex regulatory barriers, funding challenges, and provider alignment slow the growth of home-based oncology.